U.S. Markets open in 4 hrs 2 mins

Soleno Therapeutics, Inc. (SLNO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.0100+0.0389 (+4.01%)
At close: 4:00PM EDT
Sign in to post a message.
  • a
    amrish
    Going to .50 cents flop show..
  • a
    attilio
    the results released today certify that this company is dead
    Bearish
  • J
    Justin
    CNN Updates price target of SLNO to a high of $7, with 3 Buy ratings from their top analyst's. SLNO is down 43% this year, making SLNO a great investment with a lot of uptrend potential in the coming months ahead.
  • a
    attilio
    next few days: $ 0.50.....
  • a
    attilio
    now this is bankruptcy sheet thanks to senior administrators
  • s
    stockparty
    Their summary data seemed very compelling and they touted their primary data as being the linchpin to approval. They should have figured out prior to the trial that they needed to restrict the patient groups to those with full blown symptomatic PW and not included the younger group that was far from terminal, but only because of the FDA's stringent requirements. Their goal was to somehow push through a blanket approval only they know if that was an unnecessary risk to investors by virtue of the fact that they and they alone were in the trenches.
  • D
    Dale
    MACD reversal with next stop at $1.50 and then to $2 again.
  • F
    F.
    Drip, drip, drip. This company is full of it!
  • m
    mike
    strong buy ,,soon big news ,,will pay all long off
  • G
    Geoff
    I don't really post opinions but does anyone know why this stock is one of the highest options volatility stocks recently. Why is that? and thanks.
  • A
    ANDRE
    Shares of Soleno Therapeutics (SLNO) - Get Report sank Monday after the U.S. Food and Drug Administration said it needed an additional controlled clinical trial to support its new-drug application for a treatment for Prader-Willi Syndrome.

    Shares of the Redwood City, Calif., company at last check fell 44% to $1.50.

    Shares of Soleno had risen 39% this year through last week. In the past 52 weeks, the stock price has been as high as $4.39, in late May, and as low as $1.30, almost a year ago.

    Prader-Willi Syndrome is a genetic disorder that causes obesity, intellectual disability and shortness in height.

    “We intend to continue the dialogue with the FDA to ensure that DCCR is approved for individuals with PWS as expeditiously as possible,” Anish Bhatnagar, a physician who is chief executive at Soleno Therapeutics, said in a statement.

    Soleno said it had also submitted additional analyses to the FDA from the company’s Phase 3 trial:

    “Based on the totality of data generated to date, we remain confident in DCCR’s potential to address the unmet need for a safe and effective treatment option for PWS patients. We are currently evaluating the appropriate next steps for our DCCR program.”
  • A
    ANDRE
    PLEASE NOTE IT IS NOT A FAILURE OF FDA BUT, AN ADDITIONAL INVESTIGATION, READ THIS
    The data analyzes showed statistically significant changes for DCCR compared to placebo in the primary and key secondary endpoints. Following its review of the data submitted by Soleno, the FDA informed the Company on March 5, 2021 that an additional controlled clinical trial will be necessary to support an NDA submission for DCCR in PWS.
  • D
    Dan
    Going up with new information to be released👍👍👍
  • m
    mike
    I just hear negative comments in this board ...why?
  • s
    sangyeon
    I'm happy to by these stocks in 1.49. now i will keep this until 3 share!
    Bullish
  • h
    hugh
    I haven't owned this stock in a long time, but I am pretty disappointed with the FDA. This drug is safe and there are no other options out there for people with PWS. Just approve it and let the parents decide if it works for their kid!
  • d
    daniel
    anyone can tell why the price up ?no any news I checked
  • J
    Jesse
    20+ yr old company...
    down over 40% on "News"....
    Looking at where stock price has been for past 5yrs...
    Hmmm...
    Bullish
  • f
    faith
    Optimistic, it will jump back.
    Bullish
  • r
    rich
    Up almost 4 percent after hours. This is ready to move out of oversold territory.
    Bullish